Skip to content

A Clinical Trial To Study The Effect Of Kaidaryadi Ghanavati, Nimbatwagadhi Ghanavati, Patolakaturohinyadhi Ghanavati In Non Alcoholic Steato Hepatitis (NASH)

A THREE ARM EXPLORATORY COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF KAIDARYADI GHANAVATI, NIMBATWAGADHI GHANAVATI, PATOLAKATUROHINYADHI GHANAVATI IN NON ALCOHOLIC STEATO HEPATITIS (NASH)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046784
Enrollment
150
Registered
2022-10-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Sponsors

DR ROHINI HD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 2. Subjects with 1st and 2nd Grade Fatty Liver. 3. Subjects presenting with or without presence clinical features of NASH like Loss of appetite(bhubukshanasha),Fatigue(dourbhalya),Nausea(hrullasa),Vomiting(chardi),Abdominal discomfort /dull aching pain in the right Hypochondriac region (udara shoola). 4. Subjects with or without abnormal Liver Function Test (LFT). 5. Subjects fit for scheduled treatment protocol.

Exclusion criteria

Exclusion criteria: 1. Subjects with H/o Chronic Alcohol Consumption. 2. Subjects with Grade 3 and 4 Fatty Liver. 3. Subjects with T.B, HIV, HBsAg, Obstructive jaundice,Viral hepatitis, Drug induced Hepatitis, end stage liver disease and other systemic disorders. 4. Evidence of moderate to severe Ascities, Fibrosis, Cirrhosis, Splenomegaly, Jaundice, Hepatic Encephalopathy etc. 5. Pregnant women, lactating women and subjects of uncontrolled diabetes with complications.

Design outcomes

Primary

MeasureTime frame
â?¢ Improvements may be noticed in Fatty Changes of Liver on UltrasonographyTimepoint: â?¢ 1month

Secondary

MeasureTime frame
â?¢ Improvements may be noticed in Abnormal Levels of LFT. â?¢ Improvements may be noticed in BMI. â?¢ Improvements may be noticed in HbA1C reading. Timepoint: 2 months

Countries

India

Contacts

Public ContactDR ROHINI HD

Ayurveda Mahavidyalaya

drprashanthas@gmail.com9448114773

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026